These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30794663)

  • 1. Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy.
    Duchateau L; Martín-Aguilar L; Lleixà C; Cortese A; Dols-Icardo O; Cervera-Carles L; Pascual-Goñi E; Diaz-Manera J; Calegari I; Franciotta D; Rojas-Garcia R; Illa I; Clarimon J; Querol L
    PLoS One; 2019; 14(2):e0212647. PubMed ID: 30794663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy.
    Nevo Y; Ben-Zeev B; Tabib A; Straussberg R; Anikster Y; Shorer Z; Fattal-Valevski A; Ta-Shma A; Aharoni S; Rabie M; Zenvirt S; Goldshmidt H; Fellig Y; Shaag A; Mevorach D; Elpeleg O
    Blood; 2013 Jan; 121(1):129-35. PubMed ID: 23149847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD59 deficiency presenting as polyneuropathy and Moyamoya syndrome with endothelial abnormalities of small brain vessels.
    Klemann C; Kirschner J; Ammann S; Urbach H; Moske-Eick O; Zieger B; Lorenz MR; Schwarz K; Doostkam S; Ehl S; Korinthenberg R
    Eur J Paediatr Neurol; 2018 Sep; 22(5):870-877. PubMed ID: 29843966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria?
    Liberatore G; Manganelli F; Doneddu PE; Cocito D; Fazio R; Briani C; Filosto M; Benedetti L; Mazzeo A; Antonini G; Cosentino G; Jann S; Cortese A; Marfia GA; Clerici AM; Siciliano G; Carpo M; Luigetti M; Lauria G; Rosso T; Cavaletti G; Santoro L; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Schenone A; Leonardi L; Toscano A; Mataluni G; Spina E; Gentile L; Nobile-Orazio E;
    Eur J Neurol; 2021 Feb; 28(2):620-629. PubMed ID: 32959475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency.
    Ben-Zeev B; Tabib A; Nissenkorn A; Garti BZ; Gomori JM; Nass D; Goldshmidt H; Fellig Y; Anikster Y; Nevo Y; Elpeleg O; Mevorach D
    Eur J Paediatr Neurol; 2015 Nov; 19(6):688-93. PubMed ID: 26233519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy.
    Doneddu PE; De Lorenzo A; Manganelli F; Cocito D; Fazio R; Briani C; Mazzeo A; Filosto M; Cosentino G; Benedetti L; Schenone A; Marfia GA; Antonini G; Matà S; Luigetti M; Liberatore G; Spina E; Peci E; Strano C; Cacciavillani M; Gentile L; Cotti Piccinelli S; Cortese A; Bianchi E; Nobile-Orazio E
    J Neurol Neurosurg Psychiatry; 2022 Dec; 93(12):1239-1246. PubMed ID: 36190959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the EFNS/PNS diagnostic criteria in a cohort of CIDP patients.
    Athanasopoulos D; Motte J; Grüter T; Köse N; Yoon MS; Otto S; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
    Ann Clin Transl Neurol; 2021 May; 8(5):1110-1121. PubMed ID: 33826247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Demyelinating Episodes as Sole Manifestation of Inherited CD59 Deficiency.
    Solmaz I; Aytekin ES; Çağdaş D; Tan C; Tezcan I; Gocmen R; Haliloglu G; Anlar B
    Neuropediatrics; 2020 Jun; 51(3):206-210. PubMed ID: 31752029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
    Abraham A; Breiner A; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    Expert Rev Clin Immunol; 2015 Apr; 11(4):537-46. PubMed ID: 25764107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses of inflammatory polyneuropathy and chronic inflammatory demyelinating polyradiculoneuropathy identified candidate genes.
    Du Z; Lessard S; Iyyanki T; Chao M; Hammond T; Ofengeim D; Klinger K; de Rinaldis E; Shameer K; Chatelain C
    HGG Adv; 2024 Jul; 5(3):100317. PubMed ID: 38851890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study.
    Rajabally YA; Nicolas G; Piéret F; Bouche P; Van den Bergh PY
    J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1364-8. PubMed ID: 19622522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population.
    Rajabally YA; Simpson BS; Beri S; Bankart J; Gosalakkal JA
    Muscle Nerve; 2009 Apr; 39(4):432-8. PubMed ID: 19260065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HLA-DR/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients.
    Mrad M; Fekih-Mrissa N; Mansour M; Seyah A; Riahi A; Gritli N; Mrissa R
    Transfus Apher Sci; 2013 Dec; 49(3):623-6. PubMed ID: 23968987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP.
    Spina E; Doneddu PE; Liberatore G; Cocito D; Fazio R; Briani C; Filosto M; Benedetti L; Antonini G; Cosentino G; Jann S; Mazzeo A; Cortese A; Marfia GA; Clerici AM; Siciliano G; Carpo M; Luigetti M; Lauria G; Rosso T; Cavaletti G; Peci E; Tronci S; Ruiz M; Piccinelli SC; Schenone A; Leonardi L; Gentile L; Piccolo L; Mataluni G; Santoro L; Nobile-Orazio E; Manganelli F;
    J Neurol; 2022 Feb; 269(2):907-912. PubMed ID: 34173874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
    Viala K
    Int J Neurosci; 2016 Sep; 126(9):777-85. PubMed ID: 26392214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of chronic inflammatory demyelinating polyneuropathy in the South-Eastern area of Santiago, Chile.
    Cea G; Idiáquez JF; Salinas R; Matamala JM; Villagra R; Stuardo A
    J Clin Neurosci; 2020 Apr; 74():271-273. PubMed ID: 32067826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.
    Lucke IM; Wieske L; van der Kooi AJ; van Schaik IN; Eftimov F; Verhamme C
    J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated leukocyte count in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy.
    Lucke IM; Peric S; van Lieverloo GGA; Wieske L; Verhamme C; van Schaik IN; Basta I; Eftimov F
    J Peripher Nerv Syst; 2018 Mar; 23(1):49-54. PubMed ID: 29341326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.
    Dong C; Greathouse KM; Beacham RL; Palladino SP; Helton ES; Ubogu EE
    Exp Neurol; 2017 Jun; 292():35-45. PubMed ID: 28215575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.